A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

A completely new way of treating type 1 diabetes is being tested at Uppsala University Hospital. Patients are being offered ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Recently, many people have learned about semaglutides and the good they're doing for diabetes and obesity. Medications like Ozempic, Wegovy, Mounjaro, and Rybelsus have received widespread attention, ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

A diagnosis of gestational diabetes can add to the worry and stress of any pregnancy. Diabetes educator Annie Reed emphasizes ...

Robert F. Kennedy Jr., President Trump’s nominee for health secretary, doesn’t just hold fringe views on vaccines. We ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Inventiva shares climbed after the company said its treatment for diabetes and MASH appeared effective in a trial. The stock was up 15% to $2.50 after the market close on Wednesday.

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according t ...

Managing type 2 diabetes involves complex treatment, workload, and costs that impose a significant burden on individuals, impacting their physical and mental health.